Theratechnologies Inc. (THTX) Income Annual - Discounting Cash Flows
Theratechnologies Inc.
THTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
11-30
2023
11-30
2022
11-30
2021
11-30
2020
11-30
2019
11-30
2018
11-30
2017
11-30
2016
11-30
2015
11-30
2014
11-30
2013
11-30
2012
11-30
Report Filing 2025-04-09 2025-02-26 2024-02-21 2023-02-28 2022-02-24 2021-02-25 2020-02-25 2018-11-30 2017-11-30 2016-11-30 2015-11-30 2014-11-30 2014-02-27 2013-02-27
Revenue 88.66 85.87 81.76 80.06 69.82 66.05 63.22 44.05 33.23 27.6 22.55 5.9 7.13 13.66
Cost of Revenue 19.01 20.45 19.64 26.28 23.26 26.9 26.08 14.68 17.15 10.14 6.7 7.07 10.46 11.47
Gross Profit 69.65 65.42 62.13 53.78 46.56 39.15 37.14 29.38 16.07 17.47 15.85 -1.17 -3.33 2.18
Operating Expenses 56.29 57.24 72.76 93.69 71.8 57.11 45.65 32.79 24.67 14.54 12.74 6.5 3.84 6.36
Research & Development 15.14 16.88 30.37 36.94 28.27 18.02 10.84 7.77 9.19 5.65 4.11 4.95 7.09 7.08
Selling, General and Administrative 41.15 40.27 42.39 56.75 43.52 39.09 34.81 25.02 24.67 14.54 12.74 10.1 3.84 6.36
Other Operating Expenses 0 0.095 0 0 0 0 0 0 -9.19 -5.65 -4.11 -8.55 -7.09 -7.08
Operating Income 13.36 8.17 -10.63 -39.91 -25.24 -17.96 -8.51 -3.41 -8.6 2.93 3.11 -7.68 -7.17 -4.17
Net Non-Operating Interest -7.83 -8.97 -10.55 -6.18 -5.47 -5.06 -3.89 -2.24 -0.803 -1.36 -1.84 -0.877 0.417 0.739
Interest Income 1.07 1.45 0.769 0.316 0.195 0.299 1.1 0.285 0.262 0.077 0.031 0.174 0.43 0.762
Interest Expense 8.9 10.42 11.31 6.5 5.66 5.36 4.99 2.53 1.07 1.44 1.87 1.05 0.012 0.023
Equity & Other Income/(Expense) -7.08 -5.5 -2.36 -0.705 -0.957 0.369 -0.09 -0.121 -4.9 -0.792 0.335 -0.658 2.95 -10.6
Income Before Tax -1.54 -6.3 -23.54 -46.79 -31.66 -22.65 -12.5 -5.77 -14.3 0.781 1.61 -9.21 -3.8 -14.03
Income Tax Expense 2.17 2 0.421 0.443 0.063 0.016 4.99 -1.25 -0.002 0.476 0.427 0.027 0.025 0.005
Income Attributable to Non-Controlling Interest -0 0 0 0 0 0 -4.99 0 0.002 0 0 0 0 -0
Net Income -3.71 -8.31 -23.96 -47.24 -31.73 -22.67 -12.5 -4.52 -14.3 0.305 1.18 -9.24 -3.83 -14.03
Depreciation and Amortization 2.65 2.69 3.3 12.03 8.58 8.84 7.5 4.14 1.55 1.57 1.44 1 0.114 0.568
EBITDA 16.01 10.86 -7.33 -27.88 -16.66 -9.12 -1.01 0.731 -7.06 4.5 4.55 -6.68 -7.06 -3.6
Earnings Per Share (EPS) -0.075 -0.17 -0.91 -1.98 -1.37 -1.18 -0.65 -0.24 -0.78 0.019 0.06 -0.61 -0.25 -0.93
Diluted Earnings Per Share -0.075 -0.17 -0.91 -1.98 -1.37 -1.18 -0.65 -0.24 -0.78 0.018 0.075 -0.61 -0.25 -0.92
Weighted Average Shares Outstanding 49.36 49.36 26.33 23.81 23.09 19.25 19.23 18.99 18.37 16.45 19.64 15.25 15.25 15.15
Diluted Weighted Average Shares Outstanding 50.4 49.36 26.33 23.81 23.09 19.25 19.23 18.99 18.37 16.65 15.79 15.25 15.25 15.25
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us